about
Identification of SOX3 as an XX male sex reversal gene in mice and humansHIV-1 Vif and APOBEC3G: multiple roads to one goalPhosphorylation of Vif and its role in HIV-1 replicationIntrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs.Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cellsAttenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor.Is prnt a pseudogene? Identification of ram Prt in testis and ejaculated spermatozoa.Assessing combinatorial strategies to multimerize libraries of single-domain antibodies.Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replicationImproved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display.A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors.Rare double sex and mab-3-related transcription factor 1 regulatory variants in severe spermatogenic failure.Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic ApproachesCamelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity.Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins.Biosimilar DMARDs: What Does the Future Hold?Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonancePharmacoeconomics of Biosimilars: What Is There to Gain from Them?Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.Interactions Between Therapeutic Proteins and Small Molecules: The Shared Role of Perpetrators and Victims.Recombinant single-chain variable fragment and single domain antibody piezoimmunosensors for detection of HIV1 virion infectivity factor.Molecular construction of bionanoparticles: chimaeric SIV p17-HIV I p6 nanoparticles with minimal viral protein content.miRNA profiling of human naive CD4 T cells links miR-34c-5p to cell activation and HIV replication.Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells.Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradationFunctional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication.Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.M13 bacteriophage purification using poly(ionic liquids) as alternative separation matrices.Characterization of plasma labile heme in hemolytic conditions.The mutational spectrum of WT1 in male infertility.
P50
Q24320278-905E3E23-BAC0-4A2E-BD47-775E1FDD7FC6Q24564072-4ADBF0F2-C38D-43A2-B6D8-8E899D666A60Q28278306-AF3DDA40-EA8A-458C-A298-B80E453F691BQ33221441-68BADB25-FD4A-427D-AD52-B7766E8D99A6Q33367722-3523E8F1-99FB-4E28-8713-1C0618DF6E60Q33533377-4A668CE6-E100-43B6-A412-F919F411A0CAQ34291247-7356C2A4-FBA2-46A4-8C17-3F7EF64388F1Q34398905-DBA1220A-3E53-42E3-9735-F228A5802362Q34668664-E11C0E34-CD2C-45B7-A6D6-4D2D19D5FCD0Q34668776-40DF2F3F-E381-486E-B6A6-435C85BB0917Q35825343-65F11491-CB34-456C-A619-5B57B425B7DCQ35902952-60014AF0-16F6-411B-AF74-AD32F0CA1129Q35942658-0F63A46B-DED6-4F97-A529-01DD552DC0F6Q35983629-E18CA176-0781-410F-A509-9436D2562E75Q36713408-41A42690-71C3-4600-9502-9AFE366D8D93Q37252004-EEAC5C3F-003C-415E-A221-37DB1E0EC663Q38339839-304D1D0E-F09B-4B73-B37E-0E337D3977F7Q38678360-15B593F4-62C2-4344-A1EC-A45271DBF602Q38760042-D3F68ECC-B6AC-4C5E-8D96-D9519AD91AC7Q38867434-521A6B1A-BCB4-4E63-9971-7E57C7F784DAQ38893192-71F4B058-BB0A-4FB9-B714-B21B57AC83D0Q38935015-783474C7-E4CE-4A1D-A16F-3BA0D6201DB1Q38996219-E946945A-CAE3-4A8F-A402-3B290DE827CAQ39025979-D70C6D2C-2E72-4EF4-9E50-B8BE42607336Q39047005-D60B4423-1E5E-4BA3-BE09-2581E11F0CA7Q40118839-EA70E3D0-6AF0-42E6-9F41-4E2070049087Q40153257-8ABAA770-1BDC-4DEB-AC42-8D0A4E05ADF2Q40403733-2A691976-54C5-49FB-B7DD-2F5E6E43D217Q40432800-E7999E77-97C5-4334-9784-AF5FCE1CAE60Q40478201-4CB232A9-70AA-4EF2-B3E6-AA9A2FE1881BQ40485830-86A87B64-D39F-4785-9FAE-AA03BA646CB2Q40728309-46E4C126-3DB2-4E80-A02B-190BA4841312Q40968371-88F0C936-3115-48F8-B4F0-E2A855C525F8Q45195765-D6520C28-85B9-400C-8A04-E2F49960C687Q45881917-E21624D1-183A-4799-8242-703BED8B63BBQ45908273-95B84F01-90A7-4ACF-B8DA-1B01459715E0Q46036042-4194F465-E727-48F6-8801-DABD1A497FD6Q47264469-ABAF33EE-79EB-4B7B-A81D-80C6932D060CQ47680472-B8E1136A-0ACA-4549-8953-2E2FCF6F7B02Q47702981-FAE6F083-A367-48DA-9E2E-AB0B8C2D4423
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joao Goncalves
@ast
Joao Goncalves
@en
Joao Goncalves
@es
Joao Goncalves
@sl
type
label
Joao Goncalves
@ast
Joao Goncalves
@en
Joao Goncalves
@es
Joao Goncalves
@sl
prefLabel
Joao Goncalves
@ast
Joao Goncalves
@en
Joao Goncalves
@es
Joao Goncalves
@sl
P1053
B-2013-2008
P106
P21
P31
P3829
P496
0000-0002-1245-3715